openPR Logo
Press release

Nasal Drug Delivery Technology Market - 3M, Novartis AG, Pfizer Inc, Johnson and Johnson Pvt Ltd, Janssen Global Services, LLC, Becton, Dickinson and Company

10-31-2017 10:00 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

"Global Nasal Drug Delivery Technology Market- Industry Trends and Forecast to 2024"

"Global Nasal Drug Delivery Technology Market- Industry Trends and Forecast to 2024"

Latest Research on “Global Nasal Drug Delivery Technology Market accounted to USD 45.0 billion in 2016 growing at a CAGR of 7.0% during the forecast period of 2017 to 2024”. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Global Nasal Drug Delivery Technology Market, By Therapeutic Application (Nasal Congestion, Allergic & Non-Allergic Rhinitis, Vaccinations, Others), Dosage Form, (Nasal Spray, Nasal Drops & Liquids, Nasal Gels, Nasal Powders, Others), Systems (Multi Dose, Bi-Dose, Unit Dose), End Users (Hospital, Specialty Clinics, Vaccination Centers and Ambulatory Surgery Centers), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

• No of pages: 350

Get Free Sample Report @ databridgemarketresearch.com/request-a-sample/?dbmr=globa...

Report Definition:

Nasal drug delivery technology is the method of giving drug through the nasal route. The nasal route of administration helps the drug to get the direct access into systemic circulation. Drugs administered through the nasal route are accessible in various dosage forms, for example, liquid spray, liquid drops, suspension spray, Aerosol, gel etc.

• No of Figures: 60

Segmentation of Global Nasal Drug Delivery Technology Market:

By therapeutic application the global nasal drug delivery technology market is segmented into nasal congestion, allergic & non-allergic rhinitis, vaccinations, and others. By dosage form the global nasal drug delivery technology market is segmented into nasal spray, nasal drops & liquids, nasal gels, nasal powders, and others.

On the basis of systems the global nasal drug delivery technology market is segmented into multi dose, bi-dose, and unit dose.

On the basis of end-user the global nasal drug delivery technology market is segmented into hospital, specialty clinics, vaccination centers, and ambulatory surgery centers.

On the basis of geography, global nasal drug delivery technology market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Have Any Query? Ask Ours Expert @ databridgemarketresearch.com/speak-to-analyst/?dbmr=globa...

Major Market Competitors:

Some of the major players operating in global nasal drug delivery technology market are:

• 3M
• Novartis AG
• Pfizer Inc.
• Johnson and Johnson Pvt Ltd.
• Janssen Global Services, LLC
• Becton, Dickinson and Company
• Glaxosmithkline PLC
• Alkermes
• Vectura Group plc
• Kurve Technology, Inc.
• OptiNose US Inc.
• Merck & Co., Inc
• Procter & Gamble
• Teleflex Medical Europe Ltd.
• Antares Pharma
• Aradigm Corp.
• Generex Biotechnology
• AptarGroup
• pSivida Corppration
• NanoPass Technologies Ltd. among others.

Competitive Analysis:

The global nasal drug delivery technology market report is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of nasal drug delivery technology market for global, Europe, North America, Asia Pacific and South America.

• No of Tables: 220

Read more about the Nasal Drug Delivery Technology Market Visit @ databridgemarketresearch.com/reports/global-nasal-drug-de...

Summary of Market Drivers and Restraints:

• Increasing Prevalence Of Chronic Diseases
• Rising numbers of pediatric and geriatric patients
• Increasing Demand For Minimally Invasive Surgeries
• Growing Acceptance of Self-Administration Applies
• Regulatory Hindrances
• Over-The-Counter Nasal Drugs

Related Report

Global Implantable Drug Delivery Market- Industry Trends and Forecast to 2024

Global Implantable Drug Delivery Market By Product Types (Implantable Bio-Absorbable Stents, Implantable Contraceptive Drug Delivery Devices, Implantable Intraocular Drug Delivery Devices, Implantable Coronary Drug Eluting Stents, Implantable Brachytherapy Seeds and Implantable Drug Infusion Pumps), Technology (Biodegradable Implantable Drug Delivery Device Technology and Non-Biodegradable Implantable Drug Delivery Device Technology), Application (Cardiovascular, Birth Control &Contraception,Ophthalmology, Oncology And Others), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Report Access: databridgemarketresearch.com/reports/global-implantable-d...

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sales@databridgemarketresearch.com
Investor: investors@databridgemarketresearch.com
Visit Blog: databridgemarketresearch.com/blog/
Follow us on LinkedIn: www.linkedin.com/company/data-bridge-market-research

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nasal Drug Delivery Technology Market - 3M, Novartis AG, Pfizer Inc, Johnson and Johnson Pvt Ltd, Janssen Global Services, LLC, Becton, Dickinson and Company here

News-ID: 794259 • Views: 272

More Releases from Data Bridge Market Research

Tangerine Essential Oil Market Booming at a CAGR of 3.65% by 2026 with Top Key P …
The tangerine oil helps in supporting the metabolism and healthy digestion. Tangerine has a tangy and sweet aroma similar to the citrus oils. Tangerine oil is known for their cleansing properties and also for supporting the healthy respiratory and immune system. This essential oil can also be used for soothing anxious feelings and managing stress. It can also be used in any recipe specifically for citrus fruits. Global Tangerine Essential Oil
Blinds and Shades Market to Grow at a Healthy CAGR by 2026 with Top Company Anal …
Blinds and shades main function is to cover windows and is a part of the hard window coverings. They filter the light and provide privacy. Roller shades, panel blinds, roam shades/ blinds, honeycomb shades; pleated shades and other are some of the common types of the blinds and shades. They are either made of synthetic or natural fabrics and are used in residential and commercial purposes. These blinds and shades
Notoginseng Root Extract Market Analysis, Segments, Value Share, Top Company Ana …
Notoginseng is an herb mainly used for blood and circulation associated conditions. Notoginseng can be often used together with various other herbs for stopping both external and internal bleeding, It is also provided to support other effects including anti-inflammatory, immunostimulatory, anti-fibrotic, neuroprotective and others. There is increasing evidence that notoginseng has both anti-haemostatic and pro-haemostatic properties. Market Analysis: Global Notoginseng Root Extract Market Global Notoginseng Root Extract Market is expected to register
Global data center construction market Business Development Strategies 2019: Key …
This data center construction market report is the most suitable solution for your business requirements in many ways. The best tools have been adopted to generate this report which is SWOT analysis and Porter’s Five Forces analysis. Nowadays, businesses are highly relying on the different segments covered in the market research report which presents better insights to drive the business into right direction. The examination is planned for giving readers

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning